Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Pre-market Movers For Dec 7 (NFLX, ACRX, AMRN, AVGO, ZGNX)

RELATED NEWS
Trade NFLX now with 

Gainers:

AcelRx Pharmaceuticals, Inc. (ACRX: Quote) is rising 5 percent to $3.48. The company announced that it has priced its underwritten public offering of 12.5 million common shares at $3.31 per share.

Decliners:

Netflix, Inc. (NFLX: Quote) is down 0.36 percent to $85.86. Netflix disclosed that the company and its chief executive Reed Hastings each received a Wells Notice from SEC Staff about its intent to recommend to the SEC to bring a civil action for violations of fair disclosure related to statement he posted in Facebook in July about the 1 billion hour service usage.

Amarin Corporation plc (AMRN: Quote) is plunging 19 percent to $9.71. The company announced $100 million non-equity financing through a hybrid debt-like instrument. The company also noted that it is continuing to assess strategic options.

Avago Technologies Ltd. (AVGO: Quote) is falling over 2 percent to $34.30. The company announced the sale of 21.49 million ordinary shares by certain existing shareholders, including its President and chief executive and entities affiliated with certain directors.

Trading halt:

Trading in shares of Zogenix, Inc. (ZGNX: Quote) was halted.

Click here to receive FREE breaking news email alerts for Netflix Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.